Abstract
In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD)
Volume: 8 Issue: 1
Author(s): Dolores Moreno, Alexis Garcia, Diego Lema and Juan B. De Sanctis
Affiliation:
Keywords: Biomarkers, COPD, exacerbations, genetic polymorphism, lung surfactant, SP-D.
Abstract: In the recent years, a large number of potential biomarkers for Chronic Obstructive Pulmonary Disease (COPD) have been described. One of the important biomarkers is Surfactant Protein D (SPD) since serum SPD levels have been associated with lung function or health status in patients with severe COPD. Several interesting evidences of the protein and gene polymorphisms have been described. The present review highlights the current literature, recent patents and, future prospects of this important collection.
Export Options
About this article
Cite this article as:
Moreno Dolores, Garcia Alexis, Lema Diego and De Sanctis B. Juan, Surfactant Protein D in Chronic Obstructive Pulmonary Disease (COPD), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2014; 8 (1) . https://dx.doi.org/10.2174/1872214808666140209142640
DOI https://dx.doi.org/10.2174/1872214808666140209142640 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Renal and Hepatic Transporter Expression in Type 2 Diabetic Rats
Drug Metabolism Letters Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research Insulin Resistance in Type 2 Diabetes - Role of the Adipokines
Current Molecular Medicine The Role of HLA Promoters in Autoimmunity
Current Pharmaceutical Design Dendrimer-Based Contrast Agents for Molecular Imaging
Current Topics in Medicinal Chemistry Fungal Proteins with Antiproliferative and Anticancer Activities
Protein & Peptide Letters How Botulinum Toxin Type A- Occupational Therapy (OT)-Functional Electrical Stimulation (FES) Modify Spasticity and Functional Recovery in Patients with Upper Limb Spasticity Post Stroke
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry The Role of Zinc in the Treatment of Taste Disorders
Recent Patents on Food, Nutrition & Agriculture The Impact of Computer Science in Molecular Medicine: Enabling High- Throughput Research
Current Topics in Medicinal Chemistry Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection
Current Medical Imaging Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
Current Pharmaceutical Design Cardioprotective Effects of the Polyphenol Hydroxytyrosol from Olive Oil
Current Drug Targets New Insight into Urate-Related Mechanism of Cardiovascular Damage
Current Pharmaceutical Design The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Current Topics in Medicinal Chemistry Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Vascular Wall Responses to Angioplasty and Stenting: Endothelial Injury, Neointimal Hyperplasia and the Process of Restenosis
Vascular Disease Prevention (Discontinued) Bioenergetics and Mitochondrial Dysfunction in Aging: Recent Insights for a Therapeutical Approach
Current Pharmaceutical Design Management of Hyperglycemia in Gestational Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)